Table 1.
Characteristics of patients evaluated for renal transplantation at Emory Transplant Center from 2005 to 2008 by the Educational Intervention Group
| Characteristic | Study Population (n=1126) |
Preimplementation of Education Intervention (n=845; 75.0%) |
Postimplementation of Educational Intervention (n=281; 25.0%) |
P Value |
|---|---|---|---|---|
| Patient-level characteristics at evaluation start | ||||
| mean age in years (SD) | 50.5±13.3 | 50.6±13.0 | 50.7±13.3 | 0.85 |
| age category (%) | 0.63 | |||
| 20–39 years | 265 (23.5%) | 190 (22.5%) | 75 (26.7%) | |
| 40–49 years | 251 (22.3%) | 194 (23.0%) | 57 (20.3%) | |
| 50–59 years | 319 (28.3%) | 242 (28.6%) | 77 (27.4%) | |
| 60–69 years | 212 (18.8%) | 161 (19.1%) | 51 (18.2%) | |
| 70–85 years | 79 (7.0%) | 58 (6.9%) | 21 (7.5%) | |
| male (%) | 663 (58.9%) | 499 (59.1%) | 164 (58.4%) | 0.84 |
| race | 0.07 | |||
| white | 465 (41.3%) | 362 (42.8%) | 103 (36.7%) | |
| black | 661 (58.7%) | 483 (57.2%) | 178 (63.4%) | |
| cause of ESRD (%) | 0.73 | |||
| diabetes | 415 (36.9%) | 306 (36.2%) | 109 (38.8%) | |
| hypertension | 331 (29.4%) | 255 (30.2%) | 76 (27.1%) | |
| glomerulonephritis | 130 (11.6%) | 99 (11.7%) | 31 (11.0%) | |
| other | 250 (22.2%) | 185 (21.9%) | 65 (21.1%) | |
| time on dialysis | 0.04 | |||
| no dialysis | 249 (22.1%) | 201 (23.8%) | 48 (17.1%) | |
| 0–6 months | 210 (18.7%) | 160 (18.9%) | 50 (17.8%) | |
| 6–12 months | 237 (21.1%) | 177 (21.0%) | 60 (21.4%) | |
| 12–24 months | 175 (15.5%) | 132 (15.6%) | 43 (15.3%) | |
| >24 months | 255 (22.7%) | 175 (20.7%) | 80 (28.5%) | |
| Clinical and laboratory measures | ||||
| body mass index >35 kg/m2 | 163 (14.5%) | 127 (15.0%) | 26 (12.8%) | 0.36 |
| history of CVDa | 448 (39.8%) | 313 (37.0%) | 135 (48.0%) | 0.001 |
| history of cancer | 19 (1.7%) | 12 (1.4%) | 7 (2.5%) | 0.23 |
| serum albumin <3.5 g/dl at dialysis initiation | 716 (63.6%) | 531 (62.8%) | 185 (65.8%) | 0.37 |
| hemoglobin <10 g/dl at dialysis initiation | 556 (49.4%) | 411 (48.6%) | 145 (51.6%) | 0.39 |
| predialysis ESAb | 349 (31.1%) | 257 (30.4%) | 92 (32.7%) | 0.47 |
| Socioeconomic characteristics at evaluation start | ||||
| health insurance coverage | 0.25 | |||
| Medicaid | 232 (20.6%) | 182 (31.5%) | 50 (17.8%) | |
| Medicare | 245 (21.8%) | 176 (20.8%) | 69 (24.6%) | |
| private | 649 (57.6%) | 487 (57.6%) | 162 (57.7%) | |
| highest education | 0.32 | |||
| less than high school degree | 199 (17.7%) | 153 (18.1%) | 46 (16.4%) | |
| completed high school | 376 (33.4%) | 292 (34.6%) | 84 (29.9%) | |
| some college | 308 (27.4%) | 218 (25.8%) | 90 (32.0%) | |
| completed college | 215 (19.1%) | 161 (19.1%) | 54 (19.2%) | |
| unknown | 28 (2.5%) | 21 (2.5%) | 7 (2.5%) | |
| employment statusc | 0.89 | |||
| employed or full-time student | 384 (34.1%) | 284 (33.6%) | 100 (35.6%) | |
| disabled or not working | 414 (36.8%) | 315 (37.3%) | 99 (35.2%) | |
| retired | 328 (29.1%) | 246 (29.1%) | 82 (29.2%) | |
| neighborhood poverty (percent census tract below poverty) | 0.31 | |||
| <20% | 800 (71.1%) | 607 (71.8%) | 193 (68.7%) | |
| ≥20% | 326 (28.9%) | 238 (28.2%) | 88 (31.3%) |
a
CVD, cardiovascular disease (defined as history of congestive heart failure, ischemic heart disease, cardiac arrest, myocardial infarction, cardiac dysrhythmia, pericarditis, or cerebrovascular disease).
b
ESA, erythropoiesis-stimulating agent.
c
For patients with missing employment status at the time of ESRD (n=31), employment status at the time of evaluation was used.